Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vijaypd CeuticalNSE:VIJAYPD +1.51%12 EBIT per Share is ₹4.87 as of Mar. 2026. GuruFocus rates NSE:VIJAYPD with a GF Score™ of 12/100. The stock has 7 warning signs investors should review. Among 525 Healthcare Providers & Services companies, Vijaypd Ceutical ranks better than 90.29% on this metric.
Vijaypd Ceutical's EBIT per Share for the
six
months ended in Mar. 2026 was ₹4.87.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹4.87.
During the past 12 months, the average EBIT per Share Growth Rate of Vijaypd Ceutical was -40.60% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 58.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Vijaypd Ceutical's EBIT per Share or its related term are showing as below:
NSE:VIJAYPD'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 58.7 Med: 58.7 Max: 58.7
Current: 58.7
During the past 4 years, the highest 3-Year average EBIT per Share Growth Rate of Vijaypd Ceutical was 58.70% per year. The lowest was 58.70% per year. And the median was 58.70% per year.
NSE:VIJAYPD's 3-Year EBIT Growth Rate is ranked better than 90.29% of 525
companies
in the Healthcare Providers & Services industry
Industry Median: 12
vs NSE:VIJAYPD: 58.70
Vijaypd Ceutical (NSE:VIJAYPD) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Vijaypd Ceutical EBIT per Share Related Terms
Vijaypd Ceutical EBIT per Share Historical Data
* Premium members only.
The historical data trend for Vijaypd Ceutical's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For stock reported annually, GuruFocus uses latest annual data as the TTM data. EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹4.87
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vijaypd Ceutical (NSE:VIJAYPD) has a EBIT per Share of ₹4.87 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Vijaypd Ceutical and its competitors. According to the industry distribution chart, Vijaypd Ceutical ranks #51 out of 525 companies in the Healthcare Providers & Services industry, placing it in the top 9.7%.
Is Vijaypd Ceutical's EBIT per Share too high?
Vijaypd Ceutical's current EBIT per Share is ₹4.87. Based on the distribution chart, Vijaypd Ceutical ranks #51 out of 525 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Vijaypd Ceutical has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Vijaypd Ceutical's EBIT per Share compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Vijaypd Ceutical ranks #51 out of 525 companies for EBIT per Share. This places Vijaypd Ceutical in the top 10% of its industry — outperforming the majority of peers. The industry median EBIT per Share is 12.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Healthcare Providers & Services company?
The median EBIT per Share among Healthcare Providers & Services companies is 12.00, based on 525 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Vijaypd Ceutical and its competitors. For the Healthcare Providers & Services industry, the median EBIT per Share is 12.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vijaypd Ceutical's current EBIT per Share is ₹4.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vijaypd Ceutical stock overvalued right now?
Vijaypd Ceutical (NSE:VIJAYPD) has a current EBIT per Share of ₹4.87. The current EBIT per Share is ₹4.87. Vijaypd Ceutical's overall GF Score™ is 12/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Vijaypd Ceutical (NSE:VIJAYPD), the current EBIT per Share is ₹4.87 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vijaypd Ceutical Ltd is engaged in the business of distribution and supply within the pharmaceutical and consumer goods sectors, offering a comprehensive range of services. Its roles include being representatives, dealers, agents, stockists, suppliers, traders, and packers. The company offers a wide range of products serving both the pharmaceutical and wellness industries, as well as the fastmoving consumer goods (FMCG) market. Its pharmaceutical and wellness product range includes medicines such as injections, tablets, capsules, ointments, suppositories, ophthalmic preparations, and liquid oral formulations. It also supply vitamins, hormones, enzymes, wellness tonics, serums, and diagnostic test kits.
12GF Score
Get the complete analysis for NSE:VIJAYPD
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:VIJAYPD has been successfully added to your 
